Search research articles
Contact Us
Filters
Showing results (211-220 of 221) with videos related to
Page
of 23
Sort By:
JTO Clinical and Research Reports
|
May 27, 2022
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Christine M Bestvina, Jennifer G Whisenant, Valter Torri, et al.
Nature Genetics
|
July 4, 2012
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, et al.
Science Translational Medicine
|
August 5, 2016
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression
Kol Jia Yong, Daniela S Basseres, Robert S Welner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0
Sonam Puri, Natasha B Leighl, Nofisat Ismaila, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19
Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0
Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila, et al.
Cancer Discovery
|
April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
Cancer Discovery
|
July 24, 2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
Jennifer G Whisenant, Javier Baena, Alessio Cortellini, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Alessio Cortellini, Edoardo Garbo, Giulia La Cava, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 221) with videos related to
Sort By:
Page
of 23
JTO Clinical and Research Reports
|
May 27, 2022
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Christine M Bestvina, Jennifer G Whisenant, Valter Torri, et al.
Nature Genetics
|
July 4, 2012
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, et al.
Science Translational Medicine
|
August 5, 2016
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression
Kol Jia Yong, Daniela S Basseres, Robert S Welner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0
Sonam Puri, Natasha B Leighl, Nofisat Ismaila, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19
Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0
Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila, et al.
Cancer Discovery
|
April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
Cancer Discovery
|
July 24, 2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
Donna R Rivera, Solange Peters, Orestis A Panagiotou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2022
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
Jennifer G Whisenant, Javier Baena, Alessio Cortellini, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 18, 2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Alessio Cortellini, Edoardo Garbo, Giulia La Cava, et al.
Page
of 23